Spotting “Sham” Palmetto: Based on the USP Monograph, Valensa Tests Reveal Rampant Adulteration

Scientists analyzed nutritional profiles of products labeled “Saw Palmetto extract,”  finding little, if any, of the key fatty acids necessary to support prostate health;  FREE report available  ORLANDO, Florida (April 28, 2021) – Scientists from Valensa International tested market samples labeled as ‘Saw Palmetto extract’ from different suppliers and found that all the samples were […]

Read More »

Spirulina Whitepaper: Activating Immunity

Valensa International presents a new White Paper that outlines how Spirulina, dubbed a “Wonder Food,” supports the innate and acquired immune system’s army of Natural Killers, and adaptive T and B, cells. Published by Parry Nutraceuticals, Valensa’s sister company, the paper includes a comprehensive review of Spirulina’s antibacterial, antiviral and Immuno modulator effects. Read the full […]

Read More »

Valensa’s USPlus® Remains First, Only US Pharmacopeia Verified Saw Palmetto Extract For Third Year In A Row

USPlus® Pure Lipidosterolic Extract of Saw Palmetto, derived from Valensa’s GEMS Supply Chain Excellence Program, delivers an effective product and enables brands to meet emerging Amazon requirements  ORLANDO, Fla. (April 5, 2021) — Valensa International announced today that for a third consecutive year the company’s USPlus® Pure Lipidosterolic Extract of Saw Palmetto, is the only […]

Read More »

Valensa Raises the Bar in Prostate Health

New video and USPlus® logo reflect company’s commitment to truth and transparency for consumers ORLANDO, Fla. (January 27, 2021) — Since the launch of USPlus® in 2002, the industry has been faced with a dramatic shift in product quality, largely due to the proliferation of crushed saw palmetto berry powder supplements and adulterated products that […]

Read More »

From Supply Chain to Science — Get to Know Saw Palmetto Extract For Prostate Health

From Supply Chain to Science – Get to Know Saw Palmetto Extract for Prostate Health Natural Products Insider hosts a 50-minute webinar with Valensa’s own Uma Pal, CEO; Margaret H. Dohnalek, PhD, Chief Science Officer; and Larry McCarty, SVP of Production and Supply Chain. In the webinar, learn how USPlus®, a lipidosterolic saw palmetto extract supports […]

Read More »

Saw Palmetto Efficacy and Evidence: Video Series

Valensa International introduces a new Saw Palmetto video series, featuring Chief Science Officer Margaret H. Dohnalek, PhD. Dr. Dohnalek describes the breadth of research on saw palmetto lipidosterolic extract derived from this special berry, and the scientific evidence for a standardized extract that supports a healthy prostate.

Read More »

Valensa in a COVID-19 World

Dear Colleague: Please watch the brief video titled Valensa in a COVID-19 World in which our company addresses how Valensa assures the continuity of your business through comprehensive safety and quality protocols which have been enhanced to address the COVID-19 pandemic.  The video features and interesting conversation between our CEO and one of our production supervisors that […]

Read More »

Valensa Awarded U.S. Patent for Joint Pain Relief

The patent US10,624,919 covers a combination of hyaluronic acid and astaxanthin to alleviate joint deterioration, inflammation, and pain ORLANDO, Fla. (July 8, 2020) — The United States Patent and Trademark Office recently awarded Patent No. 10,624,919 to Florida-based Valensa International for the “Composition and Method to Alleviate Joint Pain Using Low Molecular Weight Hyaluronic Acid […]

Read More »

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto By Margaret H. Dohnalek, PhD, Chief Science Officer, Valensa International Controversy exists regarding whether or not saw palmetto products support prostate health and related lower urinary tract symptoms (LUTS), such as the urge to urinate, frequent urination, and waking up at night to urinate. These […]

Read More »

Study Finds FlexPro MD® Formulation Reduces Joint Pain, Inflammation in Osteoarthritis Model

New Study Validates FlexProMD’s Contribution To Mobility and Quality of Life
Nutrients, a well-respected, peer-review professional journal, published a study that finds ingredients in Valensa’s FlexProMD® reduces joint pain and inflammation in an osteoarthritis-induced model. The study builds on existing research that shows that FlexProMD® is three times more effective at relieving joint discomfort than glucosamine and chondroitin. Ask us how to incorporate this natural formulation into your product line.

Read More »